BIO3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biotest AG

Watchlist Manager

Watchlist

Price: 30.2 EUR

Market Cap: €1.2B

	Biotest AG F:BIO3	DE
	Blackrock Silver Corp XTSX:BRC	CA
S	Star7 SpA F:EH2	IT

Profitability Summary

Biotest AG's profitability score is 49/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

23%

Sustainable 3Y Average Gross Margin

34%

Gross Margin is Increasing

22% > 23%

Low Operating Margin

Sustainable 3Y Average Operating Margin

13%

Operating Margin is Increasing

-3% > 2%

Negative Net Margin

-4%

Low 3Y Average Net Margin

Net Margin is Increasing

-8% > -4%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-23% > 2%

Negative ROE

-5%

Positive 3Y Average ROE

View All

Hide

Collapse

49 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.